18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer

World Journal of Urology

Volumn 32, Issue 4, 2014, Pages 965-970

  Kjolhede H ^a   Ahlgren, G ^b   Almquist, H ^b   Liedberg, F ^b   Lyttkens, K ^b   Ohlsson, T ^b   Bratt, O ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lymphatic metastasis; PET and CT; Prostate cancer

Indexed keywords

CHOLINE; FLUORINE; FLUOROCHOLINE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ANALOGS AND DERIVATIVES; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGERY;

AGED; CHOLINE; COHORT STUDIES; FLUORINE RADIOISOTOPES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84904992319     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1189-x     Document Type: Article

References (23)

1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1): 61-71.
2. Heidenreich A, Ohlmann CH, Polyakov S (2007) Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 52(1): 29-37.
3. Hövels AM, Heesakkers RAM, Adang EM, Jager GJ, Strum S, Hoogeveen YL et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63(4): 387-395.
4. Heesakkers RA, Hövels AM, Jager GJ, van Den Bosch HC, Witjes JA, Raat HP et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9(9): 850-856.
5. Giannarini G, Petralia G, Thoeny HC (2012) Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol 61(2): 326-340.
6. Ponsky LE, Cherullo EE, Starkey R, Nelson D, Neumann D, Zippe CD (2002) Evaluation of preoperative ProstaScint scans in the prediction of nodal disease. Prostate cancer prostatic dis 5(2): 132-135.
7. Ellis RJ, Kaminsky DA, Zhou EH, Fu P, Chen W-D, Brelin A et al (2011) Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer. Int J Radiat Oncol Biol Phys 81(1): 29-34.
8. 18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176(5): 2014-2018 (discussion 2018-2019).
9. Steuber T, Schlomm T, Heinzer H, Zacharias M, Ahyai S, Chun KF et al (2010) [F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: preliminary results from a prospective histology-based study. Eur J Cancer 46(2): 449-455.
10. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology 254(3): 925-933.
11. De Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ (2003) Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44(3): 331-335.
12. Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A et al (2008) Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35(2): 253-263.
13. 18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study. BJU Int 639-643; discussion 644.
14. Schiavina R, Scattoni V, Castellucci P, Picchio M, Corti B, Briganti A et al (2008) 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54(2): 392-401.
15. 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. BJU Int 110(10): 1501-1506.
16. 18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer. Nucl Med Biol 35(2): 255-260.
17. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun 31(1): 39-45.
18. Gil-Vernet JM (1996) Prostate cancer: anatomical and surgical considerations. Br J Urol 78(2): 161-168.
19. Meijer HJM, van Lin EN, Debats O a, Witjes JA, Span PN, Kaanders JH a M et al (2011) High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 82(4): 1405-1410.
20. Mattei A, Fuechsel FG, Bhatta Dhar N, Warncke SH, Thalmann GN, Krause T et al (2008) The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 53(1): 118-125.
21. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R (2001) Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166(5): 1715-1719.
22. Evangelista L, Guttilla A, Zattoni F, Muzzio PC, Zattoni F (2013) Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate-to high-risk prostate cancer: a systematic literature review and meta-analysis. Eur Urol 63(6): 1040-1048.
23. Martino P, Scattoni V, Galosi AB, Consonni P, Trombetta C, Palazzo S et al (2011) Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). World J Urol 29(5): 595-605.